168 related articles for article (PubMed ID: 31288136)
1. Triazole substituted metal-free, metallo-phthalocyanines and their water soluble derivatives as potential cholinesterases inhibitors: Design, synthesis and in vitro inhibition study.
Arslan T; Çakır N; Keleş T; Biyiklioglu Z; Senturk M
Bioorg Chem; 2019 Sep; 90():103100. PubMed ID: 31288136
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, characterization of peripherally tetra-pyridine-triazole-substituted phthalocyanines and their inhibitory effects on cholinesterases (AChE/BChE) and carbonic anhydrases (hCA I, II and IX).
Arslan T; Buğrahan Ceylan M; Baş H; Biyiklioglu Z; Senturk M
Dalton Trans; 2020 Jan; 49(1):203-209. PubMed ID: 31808483
[TBL] [Abstract][Full Text] [Related]
3. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
[TBL] [Abstract][Full Text] [Related]
4. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel 1,2,3 triazole derivatives and assessment of their potential cholinesterases, glutathione S-transferase enzymes inhibitory properties: An in vitro and in silico study.
Çelik F; Türkan F; Aras A; Atalar MN; Karaman HS; Ünver Y; Kahriman N
Bioorg Chem; 2021 Feb; 107():104606. PubMed ID: 33476865
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
Pan L; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
Bioorg Med Chem Lett; 2008 Jul; 18(13):3790-3. PubMed ID: 18524585
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
[TBL] [Abstract][Full Text] [Related]
8. Potent acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and docking study of acridone linked to 1,2,3-triazole derivatives.
Mohammadi-Khanaposhtani M; Saeedi M; Zafarghandi NS; Mahdavi M; Sabourian R; Razkenari EK; Alinezhad H; Khanavi M; Foroumadi A; Shafiee A; Akbarzadeh T
Eur J Med Chem; 2015 Mar; 92():799-806. PubMed ID: 25636055
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticholinesterase activity of new substituted benzo[d]oxazole-based derivatives.
Pouramiri B; Moghimi S; Mahdavi M; Nadri H; Moradi A; Tavakolinejad-Kermani E; Firoozpour L; Asadipour A; Foroumadi A
Chem Biol Drug Des; 2017 May; 89(5):783-789. PubMed ID: 27863021
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of benzofuran appended benzothiazepine derivatives as inhibitors of butyrylcholinesterase and antimicrobial agents.
Mostofi M; Mohammadi Ziarani G; Lashgari N
Bioorg Med Chem; 2018 Jul; 26(12):3076-3095. PubMed ID: 29866481
[TBL] [Abstract][Full Text] [Related]
11. Investigation of potent inhibitors of cholinesterase based on thiourea and pyrazoline derivatives: Synthesis, inhibition assay and molecular modeling studies.
Mumtaz A; Majeed A; Zaib S; Ur Rahman S; Hameed S; Saeed A; Rafique H; Mughal E; Maalik A; Hussain I; Iqbal J
Bioorg Chem; 2019 Sep; 90():103036. PubMed ID: 31271943
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of benzodiazepine-1,2,3-triazole hybrid derivatives as selective butyrylcholinesterase inhibitors.
Mehrazar M; Hassankalhori M; Toolabi M; Goli F; Moghimi S; Nadri H; Bukhari SNA; Firoozpour L; Foroumadi A
Mol Divers; 2020 Nov; 24(4):997-1013. PubMed ID: 31845210
[TBL] [Abstract][Full Text] [Related]
13. Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
Purgatorio R; de Candia M; Catto M; Carrieri A; Pisani L; De Palma A; Toma M; Ivanova OA; Voskressensky LG; Altomare CD
Eur J Med Chem; 2019 Sep; 177():414-424. PubMed ID: 31158754
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors.
Mughal EU; Sadiq A; Murtaza S; Rafique H; Zafar MN; Riaz T; Khan BA; Hameed A; Khan KM
Bioorg Med Chem; 2017 Jan; 25(1):100-106. PubMed ID: 27780618
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase.
Alipour M; Khoobi M; Nadri H; Sakhteman A; Moradi A; Ghandi M; Foroumadi A; Shafiee A
Arch Pharm (Weinheim); 2013 Aug; 346(8):577-87. PubMed ID: 23852709
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.
Zhan ZJ; Bian HL; Wang JW; Shan WG
Bioorg Med Chem Lett; 2010 Mar; 20(5):1532-4. PubMed ID: 20144867
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine and its bromo-derivative as dual cholinesterase inhibitors.
Nuthakki VK; Mudududdla R; Sharma A; Kumar A; Bharate SB
Bioorg Chem; 2019 Sep; 90():103062. PubMed ID: 31220673
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity study of fluorine or chlorine-substituted cinnamic acid derivatives with tertiary amine side chain in acetylcholinesterase and butyrylcholinesterase inhibition.
Gao XH; Tang JJ; Liu HR; Liu LB; Liu YZ
Drug Dev Res; 2019 Jun; 80(4):438-445. PubMed ID: 30680760
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Benzimidazole-Based Analogs as Anti Alzheimer's Disease Compounds and Their Molecular Docking Studies.
Adalat B; Rahim F; Taha M; Alshamrani FJ; Anouar EH; Uddin N; Shah SAA; Ali Z; Zakaria ZA
Molecules; 2020 Oct; 25(20):. PubMed ID: 33092223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
